RAS Pathway Mutations and Therapeutics in Vascular AnomaliesSara Alharbi, Timothy D. Le Cras, Andrew M. Waters et al.|Pediatric Blood & Cancer|2025Cited by 11
MEK Inhibition Reduces Vascular Malformations and Gene Dysregulation in <i>NRAS</i> <sup>Q61R</sup> Human Endothelial CellsSara Alharbi, Timothy D. Le Cras, Patricia Pastura et al.|Pediatric Blood & Cancer|2026Cited by 2
Sirolimus outperforms alpelisib in models of NRASQ61R-driven vascular overgrowthSvatava Merkle, Timothy D. Le Cras, C. Griffin McDaniel et al.|Blood Vessels Thrombosis & Hemostasis|2026Cited by 0
<scp>RAS</scp> Inhibitor <scp>RMC</scp> ‐7977 Blocks Vascular Overgrowth of <i> NRAS <sup>Q61R</sup> </i> Mutant Endothelial CellsSara Alharbi, Timothy D. Le Cras, Svatava Merkle et al.|Journal of Cellular and Molecular Medicine|2026Cited by 0